Funding
← Back to your selection

GL Ventures

Activity from announced rounds

All recorded activity

GL Ventures is the Hillhouse-origin early-stage venture firm identified in LTZ and Clipto issuer announcements.

Recorded funding activity

LTZ develops cancer immunotherapies targeting myeloid biology. Clipto supplies tools for searching video and audio libraries, while Anew combines AI models and experiments for drug discovery. These histories remain distinct from the Hillhouse parent and named funds.

Sources
Rounds participated in
9
Confirmed lead rounds
1
4 roles undisclosed
New companies
9
First participation on record · 0 follow-on
Funding in participating rounds
$623M
6 disclosed · full round size, not this investor’s share

By stage

Undisclosed5
Seed2
Series B2

By primary sector

Biotech3
Robotics3
AI2
Hardware1

By country

China5
United States3
Singapore1

Rounds

9 in all activity
Anew Labs

An AI drug-discovery company that combines molecular models, experimental biology and a drug pipeline to identify and develop new medicines.

$290MFunding
Lead
Clipto

Clipto builds AI tools for searching and working with video and audio libraries.

$15MFunding
Participant
LatentVerse

LatentVerse develops foundation models that combine perception, prediction and robot action.

Participant
MoSense

MoSense builds flexible tactile skin and sensing systems for robots.

Participant
Litchibot

Litchibot develops physical-AI infrastructure that lets robot skills transfer across hardware.

Participant
LTZ Therapeutics

LTZ Therapeutics develops cancer immunotherapies that target myeloid biology.

$38MUndisclosed
Role not disclosed
Syneron Bio

Develops intelligent platform-driven macrocyclic peptide drug discovery

$150MSeries B
Role not disclosed
Dify

Helps teams build deploy and operate production-grade AI applications and agentic workflows

$30MPre-Series A
Role not disclosed
EPG

Provides modular and prefabricated data center infrastructure

$100MSeries B
Role not disclosed